Kevin Harrington, The Original Shark from Shark Tank and Inventor of The Infomercial Joins the Advisory Board of USARAD including its SecondOpinions.com® Division
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Loop | Kevin Joseph Harrington
Potential of immunotherapy in head and neck cancer | VJOncology
Scientific Advisory Board – PsiVac
Kevin Harrington, PhD on KEYNOTE-048 #ASCO2020 #ASCO
Longtime Fan Uses Ducks Hockey in His Cancer Fight
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
The value of PD-L1 as a biomarker beyond lung cancers - YouTube
Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
Professor Kevin Harrington | The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
Prof. Kevin Harrington | HSTalks
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Amazon | Targeted Therapy for Cancer (Medicine) | Syrigos, Konstantinos N., Harrington, Kevin | Oncology
Potential of immunotherapy in head and neck cancer | VJOncology
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
Scientific Lecture | Kevin Harrington | FRONTAL
T-VEC injections into melanoma lesions show significant response rate - ecancer
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
The ICR (@ICR_London) / Twitter
ESMO Immuno-Oncology Virtual Congress 2020 | #ESMOImmuno20 Virtual Congress: Prof. Kevin Harrington, Scientific Co-Chair, tells you why this event is so unique. Remember that ESMO Members register... | By ESMO - European
ESMO Immuno-Oncology Congress 2022: Who should take part in this event? - YouTube
